FemmePharma Global Healthcare, Inc., a suburban Philadelphia-based pharmaceutical persevering focus by the side of evolving tending in office block of virus and disorder suffer via women, open an Investigational New Drug submission for the treatment of breast strain. Clinical trial be scheduled to commence surrounded by the fourth quarter of 2006.
The nurturing of a treatment to alleviate breast pain come at the heels of the company’s most recent glory at developing a treatment that lessen the picky discomfort carry by endometriosis. FemmePharma Global Healthcare modern-day its treatment for endometriosis using a exceptional, patented podium technology that eliminate systemic brim effects by directed a slender but conquering amount of the pills evenly to a targeted section of the disease or unrest.
The company be in a small engineering its patented platform technology to come along a topical gel to immoderation breast pain because side effects caused by the few relatable treatment remedy are insuppressibly objectionable. “If a women be in motion to her physician today for medication to support release breast pain she obvious will be facade practical several poor quality choice: an FDA-approved prescription medication that routinely cause unpalatable side effects equal to facial barb keenness, objects gain and acne; or an over-the-counter pain reliever that execute not address the underlying causes of breast pain,” said Gerianne Tringali DiPiano, President and CEO of FemmePharma Global Healthcare.
“The insufficiency of an effective and safe and blast treatment for breast pain is why FemmePharma Global Healthcare have developed a controllable, topical treatment that should lessen side effects and unbroken efficacy,” added Dr. Peter Mays, Vice President, Pharmaceutical Development of FemmePharma Global Healthcare.
On the total, breast pain is a absolute hurdle. Roughly 26 million women moan of the disorder, and more or smaller quantity 15 percent of women deal with symptom severe mid to warrant medication.
Antibiotics be not together to a celebrated halt in juice buildup in the ear when administered to family in the vicinity sheltered ear infection. This be the finishing vertebral column of a meta-analysis of prior enquiry released against February 18, 2008 in the Archives of Otolaryngology - Head & Neck Surgery, one of the JAMA/Archives journal.
FemmePharma Global Healthcare’s pains to generate an effective treatment that overlook no adverse side effects could tender long-awaited relief for those women who suffer sharp, stabbing, shining, incorrigible pain.
According to Tringali DiPiano, womanly patients are customarily given cursory, unsatisfactory counsel on how to cope with the pain or are treat as if the disorder is a poltergeist pain. “Breast pain produce load and anxiety as women are implicated about the underlying causes of the pain. Even more vis-a-vis, breast pain is a focal rationale why physician overprescribe mammographies for youthful women,” said Tringali DiPiano.
Founded in 1996, FemmePharma Global Healthcare is fixed on developing safe and effective drugs minimize or eliminate the side effects associated with tons drug analysis by designing treatments in a line that suit the female anatomy. The company has already evaluation outstanding success with developing a safe and effective treatment for endometriosis. After gloriously completing Phase 2 study for this article of trade, it be acquire by KV Pharmaceutical who will disseminate its development and bring the drug to flea market. Other current endeavors nibble over and done with a product to treat urinary incontinence in Phase 2 clinical trials, and products to treat dysmenorrhea and dysfunctional uterine bleeding in preclinical development.
FemmePharma Global Healthcare, Inc.
Buy diet patch on AmPills.com
If you are looking for intimacy enhancer. Read this intimacy enhancer